The nation of some 25 million folks had pinned its coronavirus immunization drive on the vaccine collectively developed by British-Swedish agency AstraZeneca and Oxford college, however the authorities has since restricted the vaccine’s use as a result of hyperlinks to uncommon blood clot issues each in Australia and in Europe, notably amongst youthful folks.
The European Union’s drug regulator stated final week that it was launching a evaluation of attainable hyperlinks between the Johnson & Johnson vaccine and 4 instances of great blood clots reported in america and one other unspecified nation.
“J&J is one other viral vector vaccine, and we now have no recommendation recommending, at this level, that the federal government buy any extra viral vector vaccine,” Australian Well being Minister Greg Hunt informed reporters Tuesday, the Related Press reported.
“That’s not a mirrored image, that’s merely an remark,” he stated, including that the federal government was following the recommendation of Australia’s scientific and technical advisory group.
On Tuesday, federal well being businesses in america launched an announcement recommending a pause in J&J vaccinations as officers look into six instances of a uncommon kind of blood clot in sufferers who had lately acquired the vaccine. All six sufferers had been girls underneath the age of fifty.
In Australia, officers have opted as an alternative for added doses of the vaccine collectively developed by U.S. pharmaceutical big Pfizer with German biotech agency BioNTech to immunize youthful Australians, however that gained’t arrive till later this 12 months.
The Australian authorities has stated that Pfizer will now be the really useful vaccine for these 50 years and youthful however that the AstraZeneca vaccine will nonetheless play a key position within the nation’s vaccination drive.
“Probably the most susceptible folks in our group are usually not simply over 50, they’re really lots older than that,” Prime Minister Scott Morrison stated final week. “The AstraZeneca vaccine is nicely suited to deal with these essential susceptible teams.”
Australia has recorded two blood clot instances that its well being regulator says might be linked to the Oxford-AstraZeneca vaccine, together with a person who acquired the shot final month. The second case involving a lady in her 40s was reported this week.